Alveolar Soft Part Sarcoma
Symptoms, Doctors, Treatments, Advances & More

Alveolar Soft Part Sarcoma Overview

Save information for later
Sign Up

Learn About Alveolar Soft Part Sarcoma

What is the definition of Alveolar Soft Part Sarcoma?
Alveolar soft part sarcoma (ASPS) is a rare, slow-growing soft tissue sarcoma. Although it has been described in a variety of locations, it most commonly develops on the lower extremities in adults and in the head and neck region of children. ASPS generally presents as a soft, pain-less lump that is often not associated with any additional signs and symptoms. In many cases, the condition is not diagnosed until the affected person develops symptoms of metastasis to other sites such as the lungs, bones, central nervous system and/or liver. The underlying cause of ASPS is poorly understood. Most cases occur sporadically in people with no family history of the condition.
What are the alternative names for Alveolar Soft Part Sarcoma?
  • Alveolar soft part sarcoma
  • ASPS
Who are the top Alveolar Soft Part Sarcoma Local Doctors?
Piotr L. Rutkowski
Elite in Alveolar Soft Part Sarcoma
Piotr L. Rutkowski
Elite in Alveolar Soft Part Sarcoma
Piotr L. Rutkowski
Cracow Branch, 
Krakow, MA, PL 

Piotr Rutkowski practices in Krakow, Poland. Mr. Rutkowski is rated as an Elite expert by MediFind in the treatment of Alveolar Soft Part Sarcoma. His top areas of expertise are Melanoma, Adult Soft Tissue Sarcoma, Gastrointestinal Stromal Tumor, Lymphadenectomy, and Pancreaticoduodenectomy.

Nicholas P. Webber
Advanced in Alveolar Soft Part Sarcoma
Dr. Nicholas P. Webber
Orthopedics
Advanced in Alveolar Soft Part Sarcoma
Dr. Nicholas P. Webber
Orthopedics

Aurora Orthopedics

2801 W Kinnickinnic River Pkwy, Ste 370, 
Milwaukee, WI 
414-649-7900
Languages Spoken:
English
See accepted insurances

Nicholas Webber is an Orthopedics provider in Milwaukee, Wisconsin. Dr. Webber is rated as an Advanced provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. His top areas of expertise are Osteoarthritis, Osteonecrosis, Rhabdomyosarcoma Embryonal, Hip Replacement, and Knee Replacement.

 
 
 
 
Learn about our expert tiers
Learn More
Pamela E. Kaiser
Advanced in Alveolar Soft Part Sarcoma
Dr. Pamela E. Kaiser
Hematology | Oncology
Advanced in Alveolar Soft Part Sarcoma
Dr. Pamela E. Kaiser
Hematology | Oncology

Advocate Lutheran General Cancer Institute

1700 Luther Ln 1st & 2nd Fl, 
Park Ridge, IL 
847-268-8200
Languages Spoken:
English
See accepted insurances

Pamela Kaiser is a Hematologist and an Oncologist in Park Ridge, Illinois. Dr. Kaiser is rated as an Advanced provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. Her top areas of expertise are Angiosarcoma, Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Endoscopy.

View All Doctors
What are the latest Alveolar Soft Part Sarcoma Clinical Trials?
A Phase 2 Study of Atezolizumab With Selinexor in Alveolar Soft Part Sarcoma (AXIOM)
A Phase 2 Study of Atezolizumab With Selinexor in Alveolar Soft Part Sarcoma (AXIOM)
Enrollment Status: Recruiting
Publish Date: February 12, 2026
Intervention Type: Procedure, Drug, Biological
Study Phase: Phase 2

Summary: This phase II trial tests whether atezolizumab in combination with selinexor works to shrink tumors in patients with alveolar soft part sarcoma and whether the study drugs are better than the usual approach in treating this type of cancer. The usual approach is defined as care most people get for alveolar soft part sarcoma if they are not part of a clinical study, which includes treatment with rad...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group
Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group
Enrollment Status: Recruiting
Publish Date: February 10, 2026
Intervention Type: Other
Study Phase: Not Applicable

Summary: This trial is a translational, open-label, multi-sites, prospective and retrospective cohort study of 500 patients aimed at clinical and biological characterization of sarcoma of rare subtype. 400 patients will be included in this prospective cohort study; they will be identified in the investigating centers in the context of either routine care or a clinical study protocol. Retrospective cases of...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center